Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501.

Markus R, McBride HJ, Ramchandani M, Chow V, Liu J, Mytych D, Fanjiang G.

Adv Ther. 2019 Aug;36(8):1833-1850. doi: 10.1007/s12325-019-00979-6. Epub 2019 Jun 10. Review.


Correction: Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex.

Hao Y, Yu X, Bai Y, McBride HJ, Huang X.

PLoS One. 2019 May 28;14(5):e0217716. doi: 10.1371/journal.pone.0217716. eCollection 2019.


Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex.

Hao Y, Yu X, Bai Y, McBride HJ, Huang X.

PLoS One. 2019 May 1;14(5):e0216095. doi: 10.1371/journal.pone.0216095. eCollection 2019. Erratum in: PLoS One. 2019 May 28;14(5):e0217716.


Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab.

Hutterer KM, Polozova A, Kuhns S, McBride HJ, Cao X, Liu J.

BioDrugs. 2019 Jun;33(3):321-333. doi: 10.1007/s40259-019-00350-9.


Impact of Precipitation of Antibody Therapeutics After Subcutaneous Injection on Pharmacokinetics and Immunogenicity.

Kinderman F, Yerby B, Jawa V, Joubert MK, Joh NH, Malella J, Herskovitz J, Xie J, Ferbas J, McBride HJ.

J Pharm Sci. 2019 Jun;108(6):1953-1963. doi: 10.1016/j.xphs.2019.01.015. Epub 2019 Jan 23.


Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.

Seo N, Polozova A, Zhang M, Yates Z, Cao S, Li H, Kuhns S, Maher G, McBride HJ, Liu J.

MAbs. 2018 May/Jun;10(4):678-691. doi: 10.1080/19420862.2018.1452580. Epub 2018 Apr 20.


Novel protein therapeutic joint retention strategy based on collagen-binding Avimers.

Hulme JT, D'Souza WN, McBride HJ, Yoon BP, Willee AM, Duguay A, Thomas M, Fan B, Dayao MR, Rottman JB, Merriam K, Xie J, Smith R, Alba BM, Case RB, Dang K, Montalvan A, Grinberg N, Sun H, Black RA, Gabel CA, Sims JE, Moore K, Bakker A, Li P.

J Orthop Res. 2018 Apr;36(4):1238-1247. doi: 10.1002/jor.23756. Epub 2017 Nov 22.


Bone CLARITY: Clearing, imaging, and computational analysis of osteoprogenitors within intact bone marrow.

Greenbaum A, Chan KY, Dobreva T, Brown D, Balani DH, Boyce R, Kronenberg HM, McBride HJ, Gradinaru V.

Sci Transl Med. 2017 Apr 26;9(387). pii: eaah6518. doi: 10.1126/scitranslmed.aah6518.


Orai1 enhances muscle endurance by promoting fatigue-resistant type I fiber content but not through acute store-operated Ca2+ entry.

Carrell EM, Coppola AR, McBride HJ, Dirksen RT.

FASEB J. 2016 Dec;30(12):4109-4119. Epub 2016 Sep 1.


Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.

Kaufmann U, Shaw PJ, Kozhaya L, Subramanian R, Gaida K, Unutmaz D, McBride HJ, Feske S.

J Immunol. 2016 Jan 15;196(2):573-85. doi: 10.4049/jimmunol.1501406. Epub 2015 Dec 16.


Expression of ORAII, a plasma membrane resident subunit of the CRAC channel, in rodent and non-rodent species.

Guzman R, Valente EG, Pretorius J, Pacheco E, Qi M, Bennett BD, Fong DH, Lin FF, Bi V, McBride HJ.

J Histochem Cytochem. 2014 Dec;62(12):864-78. doi: 10.1369/0022155414554926. Epub 2014 Sep 23.


Store-operated CRAC channels regulate gene expression and proliferation in neural progenitor cells.

Somasundaram A, Shum AK, McBride HJ, Kessler JA, Feske S, Miller RJ, Prakriya M.

J Neurosci. 2014 Jul 2;34(27):9107-23. doi: 10.1523/JNEUROSCI.0263-14.2014.


Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey.

Gaida K, Salimi-Moosavi H, Subramanian R, Almon V, Knize A, Zhang M, Lin FF, Nguyen HQ, Zhou L, Sullivan JK, Wong M, McBride HJ.

J Immunotoxicol. 2015 Apr-Jun;12(2):164-73. doi: 10.3109/1547691X.2014.915897. Epub 2014 Jul 3.


Generation and characterization of fully human monoclonal antibodies against human Orai1 for autoimmune disease.

Lin FF, Elliott R, Colombero A, Gaida K, Kelley L, Moksa A, Ho SY, Bykova E, Wong M, Rathanaswami P, Hu S, Sullivan JK, Nguyen HQ, McBride HJ.

J Pharmacol Exp Ther. 2013 May;345(2):225-38. doi: 10.1124/jpet.112.202788. Epub 2013 Mar 8.


Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitors.

Gonzalez-Lopez de Turiso F, Shin Y, Brown M, Cardozo M, Chen Y, Fong D, Hao X, He X, Henne K, Hu YL, Johnson MG, Kohn T, Lohman J, McBride HJ, McGee LR, Medina JC, Metz D, Miner K, Mohn D, Pattaropong V, Seganish J, Simard JL, Wannberg S, Whittington DA, Yu G, Cushing TD.

J Med Chem. 2012 Sep 13;55(17):7667-85. doi: 10.1021/jm300679u. Epub 2012 Aug 29.


Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppression.

Dickmann LJ, McBride HJ, Patel SK, Miner K, Wienkers LC, Slatter JG.

Biochem Pharmacol. 2012 Jun 15;83(12):1682-9. doi: 10.1016/j.bcp.2012.03.001. Epub 2012 Mar 10.


Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitors.

Wu B, Wang HL, Pettus L, Wurz RP, Doherty EM, Henkle B, McBride HJ, Saris CJ, Wong LM, Plant MH, Sherman L, Lee MR, Hsieh F, Tasker AS.

J Med Chem. 2010 Sep 9;53(17):6398-411. doi: 10.1021/jm100567y.


Nuclear imaging of autoimmunity: focus on IBD and RA.

McBride HJ.

Autoimmunity. 2010 Nov;43(7):539-49. doi: 10.3109/08916931003674766. Review.


Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinase.

Pettus LH, Wurz RP, Xu S, Herberich B, Henkle B, Liu Q, McBride HJ, Mu S, Plant MH, Saris CJ, Sherman L, Wong LM, Chmait S, Lee MR, Mohr C, Hsieh F, Tasker AS.

J Med Chem. 2010 Apr 8;53(7):2973-85. doi: 10.1021/jm100095x.


Part 2: Structure-activity relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.

Wurz RP, Pettus LH, Henkle B, Sherman L, Plant M, Miner K, McBride HJ, Wong LM, Saris CJ, Lee MR, Chmait S, Mohr C, Hsieh F, Tasker AS.

Bioorg Med Chem Lett. 2010 Mar 1;20(5):1680-4. doi: 10.1016/j.bmcl.2010.01.059. Epub 2010 Jan 21.


Wnt signaling components in the chicken intestinal tract.

McBride HJ, Fatke B, Fraser SE.

Dev Biol. 2003 Apr 1;256(1):18-33.


The protein kinase Pho85 is required for asymmetric accumulation of the Ash1 protein in Saccharomyces cerevisiae.

McBride HJ, Sil A, Measday V, Yu Y, Moffat J, Maxon ME, Herskowitz I, Andrews B, Stillman DJ.

Mol Microbiol. 2001 Oct;42(2):345-53.


Degradation of the transcription factor Gcn4 requires the kinase Pho85 and the SCF(CDC4) ubiquitin-ligase complex.

Meimoun A, Holtzman T, Weissman Z, McBride HJ, Stillman DJ, Fink GR, Kornitzer D.

Mol Biol Cell. 2000 Mar;11(3):915-27.


Distinct regions of the Swi5 and Ace2 transcription factors are required for specific gene activation.

McBride HJ, Yu Y, Stillman DJ.

J Biol Chem. 1999 Jul 23;274(30):21029-36.


Long-range interactions at the HO promoter.

McBride HJ, Brazas RM, Yu Y, Nasmyth K, Stillman DJ.

Mol Cell Biol. 1997 May;17(5):2669-78.


Tagging of plant potyvirus replication and movement by insertion of beta-glucuronidase into the viral polyprotein.

Dolja VV, McBride HJ, Carrington JC.

Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10208-12.


An arts infusion intervention model for children with severe handicaps.

Sherrill C, McBride HJ.

Ment Retard. 1984 Dec;22(6):316-20. No abstract available.


The value of cerebrospinal fluid glycoprotein levels in the diagnosis of primary brain tumor.

Houck JC, McBride HJ, O'Doherty DS.

Neurology. 1968 Apr;18(4):397-402. No abstract available.


Supplemental Content

Loading ...
Support Center